Lipid Management Resource Center

eGFR Variability Linked to All-Cause Mortality Risk

Evinacumab Cuts LDL-C Level in Familial Hypercholesterolemia

For patients with homozygous familial hypercholesterolemia, evinacumab lowers low-density lipoprotein (LDL) cholesterol levels, according to a study published in the Aug. 20 issue of...
Pitavastatin Effective for Lowering Lipids, Blood Cholesterol: Study

Pitavastatin Effective for Lowering Lipids, Blood Cholesterol

Pitavastatin lowers blood total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides in a dose-dependent manner, according to a review recently published in the Cochrane...

Cardio Round-up: Sugary Drinks Bad; Opioid Treatments Good for Endocarditis; and More

Check out this week's roundup for some interesting food-and-beverage-related updates, and a potential benefit from the administration of drugs used for opioid treatment. -- Opioid Treatment,...
SGLT-2 Benefits; Shift Workers at Risk; Over-the-Counter Meds

2019 In Cardiology: Apple Heart Study Lands; Icosapent Ethyl Gets FDA Nod for New...

Another year in the books, and there were some important news stories in cardiology this year. 2091 carried big news for a few drug therapies
E-Cigarettes Take a Dangerous Toll on Heart Health

E-Cigarettes Take a Dangerous Toll on Heart Health

Electronic cigarette (e-cigarette) use negatively impacts heart disease risk factors such as cholesterol, triglycerides and blood sugar levels, according to new research being presented...
Cardio Round-up: Conversations with Cardio Experts, and More

Cardio Round-up: American Indians and AFib Risk; Benefits from Cardiac Rehab; and More

This week's edition features a look at heightened risk for atrial fibrillation in a Native American population, a study looking at the benefits of...
Evolocumab Well-tolerated as Add-on for Hypercholesterolemia Therapy

Evolocumab Well-tolerated as Add-on for Hypercholesterolemia Therapy

Evolocumab added to standard care for hypercholesterolemia was well-tolerated in a diverse patient population, a new analysis revealed. Evolocumab and other anti-PCSK9 antibodies reduced adverse...

Curated Journal Reading List